Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 701-701.
• Orginal Article • Previous Articles Next Articles
TAN Huiping
Received:2019-01-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
TAN Huiping. One Case of Anaphylactic Shock Induced by Hemocoagulase for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 701-701.
Add to citation manager EndNote|Ris|BibTeX
| [1] 赵世丹,鲁仲平.影响个例药品不良反应报告评价的因素[J].中国药物警戒,2012,9(9):553-555. [2] 郭茵,李泳桃.注射用白眉蛇毒血凝酶致低纤维蛋白原血症2例[J].药物不良反应杂志,2016,18(3) :218-220. [3] 杨成,占强.白眉蛇毒血凝酶致十二指肠溃疡出血患者低纤维蛋白原血症1例[J].中国中西医结合消化杂志,2016,24(8):642-643. [4] 王兆钺,李建琴,曹丽娟,等.长期使用蛇毒血凝酶致低纤维蛋白原血症三例报告并文献复习[J].中华血液学杂志,2014 , 35(1):50-52. [5] 潘桂华,陈玉红.注射用白眉蛇毒血凝酶致支气管痉挛1例[J].中国临床药学杂志,2005:(2):122. [6] 胡佳. 注射用白眉蛇毒血凝酶致过敏性反应1例[J].中国药业,2014,23(6):65. [7] 李萱,刘颖群,汪炜,等.白眉蛇毒血凝酶致过敏性休克死亡1例[J].法医学杂志,2011,27(1):71-72. [8] 何黎明,刘保国,陈招,等.注射用白眉蛇毒血凝酶在创伤性脑损伤患者围术期中的应用[J].实用临床医药杂志,2016,20(13):19-22. [9] 吕秋军,曹萍.药用辅料的不良反应及其安全性管理[J].药物不良反应杂志,2010,12(6):410-414. [10] 陈海涛,张临宏,昝旺.44例聚明胶肽注射液不良反应的文献分析[J].中国药物警戒,2015,12(5):296-298. [11] 袁海浪,吴晶,甘戈.59例琥珀酰明胶注射液不良反应报告分析[J].临床合理用药杂志,2016,9(3):163-164. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
